Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2009-12-16
pubmed:abstractText
To determine whether preclinical Alzheimer disease (AD), as detected by the amyloid-imaging agent Pittsburgh Compound B (PiB) in cognitively normal older adults, is associated with risk of symptomatic AD.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1538-3687
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1469-75
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed-meshheading:20008650-Aged, pubmed-meshheading:20008650-Aged, 80 and over, pubmed-meshheading:20008650-Alzheimer Disease, pubmed-meshheading:20008650-Aniline Compounds, pubmed-meshheading:20008650-Carbon Radioisotopes, pubmed-meshheading:20008650-Cognition, pubmed-meshheading:20008650-Cognition Disorders, pubmed-meshheading:20008650-Cohort Studies, pubmed-meshheading:20008650-Disease Progression, pubmed-meshheading:20008650-Female, pubmed-meshheading:20008650-Follow-Up Studies, pubmed-meshheading:20008650-Humans, pubmed-meshheading:20008650-Longitudinal Studies, pubmed-meshheading:20008650-Male, pubmed-meshheading:20008650-Middle Aged, pubmed-meshheading:20008650-Positron-Emission Tomography, pubmed-meshheading:20008650-Predictive Value of Tests, pubmed-meshheading:20008650-Thiazoles
pubmed:year
2009
pubmed:articleTitle
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
pubmed:affiliation
Alzheimer's Disease Research Center, St Louis, Missouri 63108, USA. morrisj@abraxas.wustl.edu
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural